Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PEG2000-C-DMG, a pegylated lipid, facilitates the creation of Onpattro, a hepatically targeted investigational RNAi therapeutic. This agent effectively decreases the synthesis of both mutant and wild-type transthyretin by precisely targeting the 3′ untranslated region of transthyretin mRNA [1] [2].
Description | PEG2000-C-DMG, a pegylated lipid, facilitates the creation of Onpattro, a hepatically targeted investigational RNAi therapeutic. This agent effectively decreases the synthesis of both mutant and wild-type transthyretin by precisely targeting the 3′ untranslated region of transthyretin mRNA [1] [2]. |
Molecular Weight | 2610.29 |
Formula | C126H249NO52 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PEG2000-C-DMG inhibitor inhibit